Grantham, Mayo, Van Otterloo & Co (GMO)
SGFY

Grantham, Mayo, Van Otterloo & Co (GMO)’s Signify Health, Inc. SGFY Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-916,953
Closed -$26.3M – 779
2022
Q4 		$26.3M Buy
+916,953
New +$26.5M 0.14% 146

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SGFY Position: Q1 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 916,953 shares — an estimated $26.3M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SGFY in Q4 2022 and held it in 1 quarter. The position peaked at $26.3M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 916,953 Signify Health, Inc. shares in Q1 2023, an estimated $26.3M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Signify Health, Inc. in Q4 2022 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Signify Health, Inc. position peaked at $26.3M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.